Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you miss your usual Mounjaro injection day, you can take it up to four days (96 hours) late and still stay on schedule. Beyond that point, the guidance changes. The exact decision (how to handle a late dose, whether to skip, and what to do next) belongs with your prescriber and the Patient Information Leaflet, because Mounjaro is a prescription-only medicine that requires clinical oversight. This page explains what the published guidance says and what questions are worth raising with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is some version of: "I missed my Mounjaro day, do I have to start from scratch?" The short answer is no. One late or missed dose does not reset your treatment, and it does not automatically mean a return to side effects you thought you'd moved past.
The misconception probably comes from experience with daily medicines, where a missed day feels more consequential. Because Mounjaro is once-weekly, the pharmacokinetics are more forgiving. The active ingredient, tirzepatide, has a half-life of approximately five days, meaning meaningful levels stay in your system well past your injection day. Tirzepatide's mechanism as a dual GIP and GLP-1 receptor agonist means it works through sustained receptor activation rather than a sharp daily spike, which is part of why a short delay carries less clinical weight than people assume.
That said, "forgiving" is not the same as "consequences-free". Appetite suppression and blood-glucose effects may ease off as the week progresses, and some people notice this in how hungry they feel in the days before their next injection. If you are unsure whether the timing of your injection still falls within an acceptable window, our guide to how late you can take Mounjaro sets out exactly what the guidance says about delayed doses.
The Mounjaro Summary of Product Characteristics (the clinical document behind every prescription) gives a clear practical rule. If you remember a missed dose within four days of your scheduled injection, take it as soon as you remember. Then return to your usual injection day going forward. Your schedule does not change. You do not take two doses close together to compensate.
If more than four days have passed, skip that dose entirely. Your next injection goes in on the day it was originally planned. The reasoning is straightforward: taking the dose too close to the following week's injection would put two doses within a short window, which is not how the medicine is intended to be used. You can read the current licensed guidance in the Mounjaro SmPC on the eMC, which is updated whenever the licence changes.
For the specifics of a two-day delay, this page on taking Mounjaro two days late goes into more practical detail. A three-day delay is covered separately at can you take Mounjaro three days late.
Tirzepatide's long half-life means blood levels fall gradually rather than dropping off a cliff the moment your weekly day passes. Most people will not notice a dramatic change on day five or six. Appetite may creep back slightly, and some find nausea from the previous dose has fully resolved by the time a late dose goes in, which occasionally means the late injection feels stronger than usual.
That last point matters. If you have been tolerating your current dose well but a full week or more passes before you inject, the response can feel more pronounced. This is worth flagging to your prescriber, particularly if you are mid-titration. The NHS tirzepatide medicine page summarises the common side effects and when to seek medical help, useful reference if you are unsure whether what you are feeling is expected.
Missing multiple doses across a prolonged period is a different situation. How many doses you can miss before your prescriber needs to reassess is a separate question, and it is one worth raising directly rather than guessing.
Most single late doses are low-stakes. But some situations call for a proper conversation rather than a self-directed fix. Contact your prescriber if: you have missed several weeks in a row and are unsure whether to resume at your current dose; you are due a dose increase and the missed dose complicates the timing; you have been unwell with severe vomiting or diarrhoea around the time of the missed dose; or you are using oral contraceptives and a dose-increase window is involved, the NHS England guidance on weight-management injections covers why absorption of the contraceptive pill can be affected during the first weeks of a new dose.
If you are a nume patient, our aftercare team is available seven days a week, reach us through the contact page and a member of the clinical team will respond. If you are not yet under clinical supervision and are considering starting Mounjaro, a free consultation with our prescribers is the right first step. For broader context on the treatment, the Mounjaro overview page covers eligibility, how treatment works in practice, and what a supervised course looks like.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.